• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作者对电子信件编辑提出的批评的回应是否充分:队列研究。

Adequacy of authors' replies to criticism raised in electronic letters to the editor: cohort study.

机构信息

Nordic Cochrane Centre, Rigshospitalet and University of Copenhagen, Dept 3343, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.

出版信息

BMJ. 2010 Aug 10;341:c3926. doi: 10.1136/bmj.c3926.

DOI:10.1136/bmj.c3926
PMID:20699306
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2919680/
Abstract

OBJECTIVE

To investigate whether substantive criticism in electronic letters to the editor, defined as a problem that could invalidate the research or reduce its reliability, is adequately addressed by the authors.

DESIGN

Cohort study.

SETTING

BMJ between October 2005 and September 2007. Inclusion criteria Research papers generating substantive criticism in the rapid responses section on bmj.com.

MAIN OUTCOME MEASURES

Severity of criticism (minor, moderate, or major) as judged by two editors and extent to which the criticism was addressed by authors (fully, partly, or not) as judged by two editors and the critics.

RESULTS

A substantive criticism was raised against 105 of 350 (30%, 95% confidence interval 25% to 35%) included research papers, and of these the authors had responded to 47 (45%, 35% to 54%). The severity of the criticism was the same in those papers as in the 58 without author replies (mean score 2.2 in both groups, P=0.72). For the 47 criticisms with replies, there was no relation between the severity of the criticism and the adequacy of the reply, neither as judged by the editors (P=0.88 and P=0.95, respectively) nor by the critics (P=0.83; response rate 85%). However, the critics were much more critical of the replies than the editors (average score 2.3 v 1.4, P<0.001).

CONCLUSIONS

Authors are reluctant to respond to criticisms of their work, although they are not less likely to respond when criticisms are severe. Editors should ensure that authors take relevant criticism seriously and respond adequately to it.

摘要

目的

调查作者是否充分解决了电子信件编辑中的实质性批评,这些批评被定义为可能使研究无效或降低其可靠性的问题。

设计

队列研究。

设置

BMJ 在 2005 年 10 月至 2007 年 9 月之间。纳入标准:在 bmj.com 的快速回复部分生成实质性批评的研究论文。

主要观察指标

两位编辑判断的批评严重程度(轻微、中度或严重),以及两位编辑和批评者判断的作者对批评的处理程度(完全、部分或不处理)。

结果

对 350 篇纳入研究论文中的 105 篇(30%,95%置信区间 25%至 35%)提出了实质性批评,其中作者对 47 篇(45%,35%至 54%)作出了回应。批评的严重程度与未回复作者的 58 篇论文相同(两组平均评分为 2.2,P=0.72)。对于有回复的 47 个批评意见,编辑(P=0.88 和 P=0.95)和批评者(P=0.83)判断的批评严重程度与回复的充分性之间均无关系。然而,批评者对回复的批评比编辑更为严厉(平均评分 2.3 对 1.4,P<0.001)。

结论

尽管在批评严重时,作者不太可能不回复批评,但他们不愿回复批评。编辑应确保作者认真对待相关批评并作出充分回应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ce/4787641/37cb9c070515/goep748350.f1_default.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ce/4787641/37cb9c070515/goep748350.f1_default.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ce/4787641/37cb9c070515/goep748350.f1_default.jpg

相似文献

1
Adequacy of authors' replies to criticism raised in electronic letters to the editor: cohort study.作者对电子信件编辑提出的批评的回应是否充分:队列研究。
BMJ. 2010 Aug 10;341:c3926. doi: 10.1136/bmj.c3926.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Differences in review quality and recommendations for publication between peer reviewers suggested by authors or by editors.作者推荐的同行评审员与编辑推荐的同行评审员之间在评审质量和出版建议方面存在差异。
JAMA. 2006 Jan 18;295(3):314-7. doi: 10.1001/jama.295.3.314.
4
Authorship criteria and disclosure of contributions: comparison of 3 general medical journals with different author contribution forms.作者资格标准与贡献披露:3种具有不同作者贡献形式的综合医学期刊的比较
JAMA. 2004 Jul 7;292(1):86-8. doi: 10.1001/jama.292.1.86.
5
Importance of free access to research articles on decision to submit to the BMJ: survey of authors.关于决定向《英国医学杂志》投稿时免费获取研究文章的重要性:作者调查
BMJ. 2006 Feb 18;332(7538):394-6. doi: 10.1136/bmj.38705.490961.55. Epub 2006 Jan 9.
6
Postpublication criticism and the shaping of clinical knowledge.
JAMA. 2002 Jun 5;287(21):2843-7. doi: 10.1001/jama.287.21.2843.
7
Survey of conflict-of-interest disclosure policies of ophthalmology journals.眼科期刊利益冲突披露政策调查。
Ophthalmology. 2009 Jun;116(6):1093-6. doi: 10.1016/j.ophtha.2008.12.053. Epub 2009 Apr 19.
8
Association between women's authorship and women's editorship in infectious diseases journals: a cross-sectional study.女性作者与女性编辑在传染病学期刊中的关联:一项横断面研究。
Lancet Infect Dis. 2022 Oct;22(10):1455-1464. doi: 10.1016/S1473-3099(22)00367-X. Epub 2022 Jul 12.
9
More than one-third of Cochrane reviews had gift authors, whereas ghost authorship was rare.超过三分之一的 Cochrane 综述有馈赠作者,而幽灵作者则很少见。
J Clin Epidemiol. 2020 Dec;128:13-19. doi: 10.1016/j.jclinepi.2020.08.004. Epub 2020 Aug 8.
10
ChatGPT: Detection in Academic Journals is Editors' and Publishers' Responsibilities.ChatGPT:学术期刊的检测是编辑和出版商的责任。
Ann Biomed Eng. 2023 Oct;51(10):2103-2104. doi: 10.1007/s10439-023-03247-5. Epub 2023 May 27.

引用本文的文献

1
Post-publication critique at top-ranked journals across scientific disciplines: a cross-sectional assessment of policies and practice.跨学科顶级期刊发表后评论:政策与实践的横断面评估
R Soc Open Sci. 2022 Aug 24;9(8):220139. doi: 10.1098/rsos.220139. eCollection 2022 Aug.
2
Letters to the editor on the Zika virus: a bibliometric analysis.致编辑的关于寨卡病毒的信:文献计量分析。
J Med Libr Assoc. 2021 Apr 1;109(2):301-310. doi: 10.5195/jmla.2021.903.
3
Understanding the nature and scope of clinical research commentaries in PubMed.

本文引用的文献

1
No short-cut in assessing trial quality: a case study.评估试验质量没有捷径:一个案例研究。
Trials. 2009 Jan 7;10:1. doi: 10.1186/1745-6215-10-1.
2
International Committee of Medical Journal Editors (ICMJE): Uniform Requirements for Manuscripts Submitted to Biomedical Journals: writing and editing for biomedical publication.国际医学期刊编辑委员会(ICMJE):向生物医学期刊投稿的统一要求:生物医学出版物的写作与编辑
Haematologica. 2004 Mar;89(3):264.
3
Postpublication criticism and the shaping of clinical knowledge.
理解 PubMed 中临床研究评论的性质和范围。
J Am Med Inform Assoc. 2020 Mar 1;27(3):449-456. doi: 10.1093/jamia/ocz209.
4
Letters to the editor in response to studies of guns in the home and homicide and suicide.致编辑的信:回应关于家中枪支与凶杀及自杀的研究
Inj Epidemiol. 2017 Dec;4(1):3. doi: 10.1186/s40621-016-0100-9. Epub 2017 Feb 6.
5
What do letters to the editor publish about randomized controlled trials? A cross-sectional study.致编辑的信中发表了哪些关于随机对照试验的内容?一项横断面研究。
BMC Res Notes. 2013 Oct 14;6:414. doi: 10.1186/1756-0500-6-414.
6
Standards in the face of uncertainty--peer review is flawed and under-researched, but the best we have.面对不确定性的标准——同行评审存在缺陷且研究不足,但却是我们现有的最佳方式。
Dtsch Arztebl Int. 2012 Dec;109(51-52):900-2. doi: 10.3238/arztebl.2012.0900. Epub 2012 Dec 24.
7
Designing next-generation platforms for evaluating scientific output: what scientists can learn from the social web.设计下一代评价科研产出的平台:科学家可以从社交网络中学到什么。
Front Comput Neurosci. 2012 Oct 1;6:72. doi: 10.3389/fncom.2012.00072. eCollection 2012.
8
Decoupling the scholarly journal.解开学术期刊的束缚。
Front Comput Neurosci. 2012 Apr 5;6:19. doi: 10.3389/fncom.2012.00019. eCollection 2012.
9
Five years of Trials.五年的试验。
Trials. 2011 Nov 23;12:248. doi: 10.1186/1745-6215-12-248.
JAMA. 2002 Jun 5;287(21):2843-7. doi: 10.1001/jama.287.21.2843.
4
Poor-quality medical research: what can journals do?低质量医学研究:期刊能做些什么?
JAMA. 2002 Jun 5;287(21):2765-7. doi: 10.1001/jama.287.21.2765.
5
Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis.荟萃分析过程中遇到的抗真菌药物试验设计与报告中的问题。
JAMA. 1999 Nov 10;282(18):1752-9. doi: 10.1001/jama.282.18.1752.
6
Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis.196项类风湿性关节炎非甾体抗炎药双盲试验报告中的方法学以及显性和隐性偏差。
Control Clin Trials. 1989 Mar;10(1):31-56. doi: 10.1016/0197-2456(89)90017-2.